openPR Logo
Press release

RNA Sequencing Market Opportunities Esitimate To Grow At High Significant Rate Throughout The Forecast Period

11-15-2018 12:53 PM CET | Health & Medicine

Press release from: Allied Market Research

RNA Sequencing Market

RNA Sequencing Market

Global RNA Sequencing Market report it provides a vital recent industry data which covers in general market situation along with future scenario for industry around the Globe. It also consist of major data along with forecasts of a global market along with clear presentation of diagrams (charts and tables).

RNA sequencing or whole transcriptome shotgun sequencing is a process to identify the presence and quantity of RNA present in a biological sample. It enables to analyze the constantly changing cellular transcriptome; identifies gene fusion, post transcriptional modifications, & splicing; and recognizes the exon/intron boundary of the eukaryotic genes.

Advancements of in sequencing technology, increase in acceptance of NGS technology, and growth in number of partnerships & collaborations drive the growth of the global RNA sequencing market. However, dearth of skilled professionals and problems associated with storage of sequencing data restrain the market growth. Government initiatives in population sequencing and emerging markets such as China & India offer significant growth opportunities for the market growth.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-toc-and-sample/2980?utm_source=sy-Openpr

The market is dominated by players such as
• Affymetrix Inc.
• Thermo Fisher Scientific Inc.
• Agilent Technologies Inc.
• Bio-Rad Laboratories Inc.
• GE Healthcare
• Illumina Inc.
• Qiagen N.V.
• F. Hoffmann-La Roche Ltd.
• Sigma Aldrich
• Fluidigm Corporation.

The RNA sequencing market in segmented on the basis of products & services, technology, application, end user, and region. Based on products & services, the market is categorized into sample preparation, sequencing platforms & consumables for RNA sequencing; RNA sequencing services; and data analysis, storage, and management. Sample preparation is subsegmented into application and method.

Based on technology, the market is classified into sequencing by synthesis (SBS), ion semiconductor sequencing, single-molecule real-time (SMRT) sequencing, and nanopore sequencing. Applications covered in the study include de novo transcriptome assembly, expression profiling analysis, variant calling & transcriptome epigenetics, and small RNA sequencing.

According to end user, the market is divided into research centers and academic & government institutes, hospitals & clinics, pharmaceutical & biotechnology companies, and others (nonprofit organizations, agrigenomics organizations, and consumer genomics companies). Geographically, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA)…

For More Information @ https://www.alliedmarketresearch.com/purchase-enquiry/2980?utm_source=sy-Openpr

Key Benefits
• The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
• Comprehensive analysis of all geographical regions is provided, which helps to determine the prevailing opportunities.
• Key players are profiled and their strategies are analyzed thoroughly, which help to understand competitive outlook of the global market.
• The report offers a quantitative analysis from 2017 to 2023, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
• Exhaustive analysis of the RNA sequencing market by type helps to understand the types of sequencing technologies that are currently being used along with the variants that are expected to gain prominence in the future.

Access Full Summery @ https://www.alliedmarketresearch.com/rna-sequencing-market?utm_source=sy-Openpr

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release RNA Sequencing Market Opportunities Esitimate To Grow At High Significant Rate Throughout The Forecast Period here

News-ID: 1373374 • Views:

More Releases from Allied Market Research

Sports Training Market Size Worth USD $18.85 Billion by 2031, Growth Rate (CAGR) of 5.7% From 2022 to 2031
Sports Training Market Size Worth USD $18.85 Billion by 2031, Growth Rate (CAGR) …
According to a new report published by Allied Market Research, titled, "Sports Training Market by Sports Type, by Form, by Application, by Age Group, by Medium: Global Opportunity Analysis and Industry Forecast, 2021-2031". The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and changing market trends. The Sports Training Market Size was valued at $11.00 billion
Medical Display Market Size, Top Companies, Share, Growth And Forecast 2033
Medical Display Market Size, Top Companies, Share, Growth And Forecast 2033
Allied Market Research has recently published a comprehensive research study titled "Global Medical Display Market: Outlook and Forecast 2023-2032." This study conducts a thorough risk analysis of the market, identifies promising opportunities, and provides strategic and tactical decision-making support for the period from 2023 to 2030. The market analysis is segmented by key regions that are instrumental in driving market growth. The report offers valuable insights into market research and
Topical Pain Relief Market Size, Top Companies, Share, Growth And Forecast 2033 | CAGR 3.7%
Topical Pain Relief Market Size, Top Companies, Share, Growth And Forecast 2033 …
Topical Pain Relief Market- Global Outlook and Forecast 2023-2032 is latest research study released by Allied Market Research evaluating the market risk side analysis, highlighting opportunities and leveraged with strategic and tactical decision-making support (2023-2032). The market Study is segmented by key a region that is accelerating the marketization. The report provides information on market research and development, growth drivers, and the changing investment structure of the Global Topical Pain
Anti-Obesity Drugs Market Size, Top Companies, Share, Growth And Forecast 2033 | CAGR 10.7%
Anti-Obesity Drugs Market Size, Top Companies, Share, Growth And Forecast 2033 | …
Allied Market Research has recently released the latest research study titled "Anti-Obesity Drugs Market: Global Outlook and Forecast 2023-2032." This comprehensive analysis thoroughly evaluates market risks, identifies potential opportunities, and offers valuable support for strategic decision-making between 2023 and 2030. The study meticulously dissects the Anti-Obesity Drugs Market, segmenting it by key regions that significantly contribute to its rapid growth. This report serves as a comprehensive resource, providing insights into

All 5 Releases


More Releases for RNA

Global RNA Analysis/Transcriptomics Market Report
The Global RNA Analysis / Transcriptomics Market is projected to expand at a CAGR of 12.5% during the forecast period, to hit USD 8.1 Billion by 2026, according to a recent market report compiled by Global Market Estimates. Due to the rising need for personalized medicines, the demand for RNA Analysis / Transcriptomics is expected to raise the market demand. Browse 156 Market Data Tables and 112 Figures spread through 175
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may
Senior experts from Exicure, Roche, GSK, BioNTech RNA Pharmaceuticals & MiNA The …
With less than 4 weeks until SMi’s 10th annual RNA Therapeutics event (http://www.therapeutics-rna.com/openpr) opens its doors in London, UK next month, registration will soon be closing and delegate places are becoming increasingly limited. Over the course of 2 focused days, attendees will be able to have an exclusive look into key developments in oligonucleotide therapeutics, mRNA technology, delivery mechanisms, and much more, led by industry leaders, scientific pioneers, and academics exploring
RNA Therapy Improves Vision in Child Blindness, hear more about recent developme …
SMi Reports: In light of recent developments in the field of RNA Therapy, SMi’s 10th Annual RNA Therapeutics is set to deliver the latest advancements in February this year. Leber congenital amaurosis (LCA), one of the most common causes of blindness in children, has been the subject of successful RNA therapy as researchers at the University of Pennsylvania recently published new data showing the success of the new therapy which improved
New Confirmed Delegates & Speakers for RNA Therapeutics
SMi are thrilled to welcome Dr. James Hamilton, Vice President, Head of Clinical Development, Arrowhead Pharmaceuticals onto the speaker panel RNA Therapeutics 2018! Dr. James Hamilton is currently responsible for all aspects of clinical trial design, implementation and execution. In this role, Dr. Hamilton managed the ARC-520 and ARC-AAT global programs through Phase 2 of development. Previously, Dr. Hamilton was Medical Director and Head of Corporate Development at Arrowhead. He led
Introducing the 9th Annual RNA Therapeutics 2018
As the requirement for targeted solutions for chronic diseases continues to grow, the interest of pharmaceutical and biotech companies has increasingly focused towards RNA therapeutics, such that by 2020, the RNA Therapeutics Market is predicted to attain $1.2 billion. One of the main challenges in RNA Therapeutics continues to be bridging the gap between in-vivo and in-vitro models, hear key case studies on the development on the latest delivery systems and